The Latest Cardiac and Vascular News
New Board appointments strengthen Tenax with world-class expertise in cardiovascular drug development, commercial strategy, and business development New Directors will provide significant guidance as Tenax is poised to advance its two leading drug candidates into late-stage clinical testing Transformational step as Tenax strengthens its positioning as a leading specialty pharmaceutical […]
Introducing a mammal-derived genome engineering enzyme for next-generation gene and cell therapy Financing to fund SalioGen’s pipeline in genetic diseases, based on proprietary EDIT ‘gene coding’ platform to advance durable, safe and affordable non-viral gene therapies Financing concurrent with strengthening of board of directors and scientific advisory board BURLINGTON, Mass., […]
CHICAGO, March 1, 2021 /PRNewswire/ — Hillrom (NYSE: HRC) today provided an update on its planned acquisition of Bardy Diagnostics, Inc. (BardyDx), which it previously announced on January 19, 2021. On January 29, 2021, a Medicare Administrative Contractor, Novitas Solutions, published new Category 1 reimbursement rates applicable to the Current Procedural Terminology (CPT) codes for the […]
RADNOR, Pa., Feb. 27, 2021 /PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP reminds iRhythm Technologies, Inc. (NASDAQ: IRTC) (“iRhythm”) investors that a securities fraud class action lawsuit has been filed against iRhythm on behalf of those who purchased or acquired iRhythm common stock between August 4, 2020 and January 28, 2021, inclusive […]
NEW YORK, March 01, 2021 (GLOBE NEWSWIRE) — PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, today announced that the Advanced Medical Technology Association (AdvaMed), the world’s leading medical technology trade association, has appointed Lishan Aklog, M.D., PAVmed’s Chairman and Chief Executive […]
Record Quarterly Revenue of $29.3 million in Q4 2020, up 149% year over year and up 22% from Q3 2020 Operating loss of $1.8 million in Q4 2020, a 74% improvement year over year Record Quarterly Adjusted EBITDA of $2.2 million in Q4 2020, achieving quarterly positive Adjusted EBITDA for […]
Series C round led by RTW Investments, LP; RA Capital Management; Fidelity Management & Research Company; and funds and accounts advised by T. Rowe Price Associates, Inc.; and joined by existing investors including The Column Group, Casdin Capital and GV. Funds will help advance lead gene therapy program in hypertrophic […]
Reflects Company’s Evolution to Offering Digital Health Framework Complementing its Capital Equipment Technologies IRVINE, Calif.–(BUSINESS WIRE)–Nihon Kohden, a U.S. market leader in precision medical products and services, today announced that it is rebranding Nihon Kohden USLab, its Irvine-based R&D and product development subsidiary, to Nihon Kohden Digital Health Solutions Inc. […]
ENGLEWOOD, Colo., Feb. 25, 2021 /PRNewswire/ — 2020 Full Year Revenue increased 76% year over year to $80.1 million Orders increased 96% Net income of $9.1 million; Diluted EPS $0.26 Adjusted EBITDA $13.7 millio 2020 Revenue and Adjusted EBITDA are the highest in Company history 2020 Fourth Quarter Revenue increased 81% year over year to $25.6 million Orders […]
SAN FRANCISCO, Feb. 25, 2021 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today reported financial results for the three months and full year ended December 31, 2020. Fourth Quarter 2020 Financial Highlights Revenue of $78.8 million […]
